Medovate and JEB Technologies have become part of the same group structure. The two companies will integrate their management, unique skill sets and expertise to drive greater collaboration, innovation and growth in the dynamic field of medical device development.
Medovate and JEB Technologies will combine their strengths across the full medical device development pipeline, from concept design, product development and manufacturing, through to successful regulatory approvals and global market launches. Medovate's unique approach to developing technologies in collaboration with the NHS will be complemented by JEB's extensive manufacturing experience – spanning over 50 years – in developing, manufacturing, and commercialising products globally.
Stuart Thomson, Vice President of Business Development, said: “This is a significant step forward for the medical device industry in the UK’s eastern region, leveraging our organisations’ collective strengths and expertise, along with our respective medical technology pipelines, to accelerate the development of innovative UK medical devices and launch them successfully around the world. Medovate's experienced team will work seamlessly with JEB Technologies to drive innovation development which will positively impact healthcare globally.”
JEB Technologies, with over five decades of experience since its establishment in 1972, specialises in designing, developing and manufacturing a diverse range of medical and industrial products. They offer an end-to-end product development and manufacturing service, contributing their expertise from concept to commercialisation. JEB collaborates with medical professionals, innovators and consultants to bring innovative medical ideas to life. JEB Technologies portfolio consists of recently launched prostate biopsy device Camprobe, Transicap and exciting further products currently in development.
Medovate is recognised for its dedication to providing a route to market for clinician-inspired medical device innovations. Celebrating its fifth anniversary last year Medovate's portfolio spans anaesthesia, airway and surgical products, including the pioneering SAFIRA system for regional anaesthesia, Glucosave, Lumevac and Humidicare.
Sean Licence Vice President of Operations added: “Developing cutting-edge medical devices involves complex engineering challenges, regulatory requirements and market demands. By uniting Medovate's clinician-inspired model with JEB Technologies' worldwide manufacturing and design proficiency, we will drive innovation and strengthen our offering to both the medical technology industry and healthcare providers.”
Both companies share not only a geographical proximity in the East of England, but also a commitment to excellence in Medtech innovation. Medovate and JEB Technologies combining forces signifies a strategic move to enhance their collective impact on the Medtech landscape, promising a bright future for groundbreaking medical device development from the UK.
